Hollencrest Capital Management Albemarle Corp Transaction History

Hollencrest Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$108.73 - $146.89 $7,502 - $10,135	-69 Reduced 31.94%	147 $19,000
Q4 2023 Feb 14, 2024	SELL	$113.26 - $170.8 $2,604 - $3,928	-23 Reduced 9.62%	216 $31,000
Q3 2023 Nov 13, 2023	BUY	$162.63 - $243.44 $1,951 - $2,921	12 Added 5.29%	239 $40,000
Q2 2023 Aug 10, 2023	SELL	$172.91 - $232.22 $12,103 - $16,255	-70 Reduced 23.57%	227 $50,000
Q1 2023 May 16, 2023	BUY	$208.49 - $290.15 $1,042 - $1,450	5 Added 1.71%	297 $65,000
Q4 2022 Feb 06, 2023	BUY	$214.02 - $325.38 $62,493 - $95,010	292 New	292 $63,000

909

104M

8.35M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $9.86B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

Stay updated on Hollencrest Capital Management with notifications on news.